Eva-maria M. Varga

Graz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Engineering of structural variants of the major peanut allergens Ara h 2 and Ara h 6 for allergen-specific immunotherapy.

Engineering of structural variants of the major peanut allergens Ara h 2 and Ara h 6 for allergen-specific immunotherapy.

Journal: The Journal of allergy and clinical immunology

Published: May 08, 2018

Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project.

Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project.

Journal: Allergy

Published: November 12, 2017

EAACI guidelines on allergen immunotherapy: Prevention of allergy.

EAACI guidelines on allergen immunotherapy: Prevention of allergy.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: September 10, 2017

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

Journal: Clinical and translational allergy

Published: August 24, 2017

Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review.

Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review.

Journal: Clinical and translational allergy

Published: August 24, 2017

Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products.

Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products.

Journal: Allergy

Published: July 29, 2017

Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy.

Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy.

Journal: Allergy

Published: July 29, 2017

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews.

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews.

Journal: Clinical and translational allergy

Published: April 19, 2017

Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.

Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.

Journal: Molecular immunology

Published: November 30, 2016

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Journal: Clinical and translational allergy

Published: September 25, 2016

Type 1 diabetes in children and adolescents is not associated with a reduced prevalence of atopy and allergic diseases.

Type 1 diabetes in children and adolescents is not associated with a reduced prevalence of atopy and allergic diseases.

Journal: Pediatric diabetes

Published: September 23, 2016

Fel d 1 synthetic peptides (Cat-PAD) - Good news for cat owners with children?

Fel d 1 synthetic peptides (Cat-PAD) - Good news for cat owners with children?

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: June 12, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026